Simvastatin Tablets, USP 40 mg. Rx Only 1000 Count Bottles Manufactured by: Aurolife Pharma LLC D...

FDA Drug Recall #D-1842-2019 — Class III — July 29, 2019

Recall Summary

Recall Number D-1842-2019
Classification Class III — Low risk
Date Initiated July 29, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Aurobindo Pharma USA Inc.
Location East Windsor, NJ
Product Type Drugs
Quantity 2,352/1000 count bottles

Product Description

Simvastatin Tablets, USP 40 mg. Rx Only 1000 Count Bottles Manufactured by: Aurolife Pharma LLC Dayton NJ 08810 Manufactured for: Aurobindo Pharma USA, Inc. Dayton, NJ 08810 NDC 65862-053-99

Reason for Recall

Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B

Distribution Pattern

Product was distributed nationwide by three major distributors who may have further distributed the product.

Lot / Code Information

05318054B, exp 3/2021

Other Recalls from Aurobindo Pharma USA Inc.

Recall # Classification Product Date
D-0492-2024 Class II Clorazepate Dipotassium Tablets, USP, 7.5 mg, a... Apr 24, 2024
D-0491-2024 Class II Clorazepate Dipotassium Tablets, USP, 3.75 mg, ... Apr 24, 2024
D-1171-2023 Class II Rasagiline Tablets 0.5mg, 30-count bottle, Rx o... Aug 2, 2023
D-1087-2023 Class II Rufinamide Tablets, USP 200 mg, packaged in 120... Jul 21, 2023
D-1088-2023 Class II Rufinamide Tablets, USP 400 mg, packaged in 120... Jul 21, 2023

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.